| Financial Year |
March 31 2023 |
| Monetary Funds |
451,741,411.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
10,011,186.41 |
| Advances to Suppliers |
6,452,005.70 |
| Other Receivables |
220,169,633.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,142,572,399.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
280,984,238.29 |
| Total Current Assets |
11,111,930,874.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
348,317,133.30 |
| Investment Properties |
893,888,932.90 |
| Fixed Assetes |
34,177,551.86 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,007,473.05 |
| R&D expenses |
-- |
| Goodwill |
10,933,697.32 |
| Long-Term Deferred and Prepaid Expenses |
356,879.82 |
| Deferred Income Tax Assets |
412,617,174.97 |
| Other Non-Current Assets |
33,776,120.59 |
| Sub-Total of Non-Current Assets |
2,553,575,065.20 |
| Total Assets |
13,665,505,939.95 |
| Short-Term Loans |
897,995,212.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
498,223,809.32 |
| Accounts Received In Advance |
6,983,467.09 |
| Employee Compensation Payable |
24,195,482.25 |
| Taxes Payable |
409,011,354.40 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
173,186,860.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
916,477,098.82 |
| Other Current Liabilities |
1,281,939,495.37 |
| Sub-Total of Current Liabilities |
5,657,953,763.89 |
| Long-term Loans |
1,393,946,355.61 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,414,946,355.61 |
| Total Liabilities |
7,072,900,119.50 |
| Paid-In Capital(Or Share Stock) |
1,109,830,895.00 |
| Capital Surplus |
2,312,816,085.07 |
| Surplus Reserve |
262,840,126.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,784,431,436.13 |
| Minority Stockholder's Interest |
1,122,687,278.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,469,918,542.39 |
| Owner's Equity（Stockholder's Equity） |
6,592,605,820.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,665,505,939.95 |
